Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amino Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115160162A details an iridium-catalyzed method for synthesizing chiral beta-hydroxy alpha-amino acid derivatives with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN116102464B details asymmetric hydrogenation for high-purity chiral amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103906728B reveals a novel catalytic method for tertiary aminoalcohol synthesis, offering significant supply chain and cost advantages for fine chemical intermediates manufacturing.
Patent CN102344378B details aqueous hydrogenation for amino alcohol. Offers high purity and yield for pharmaceutical supply chains.
Novel visible-light method for amino acids. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN121045179A details efficient synthesis. Offers supply chain stability and cost advantages for pharmaceutical intermediate manufacturing partners globally.
Novel route for Dapoxetine HCl using chiral organocatalyst. High yield, >99% ee. Ideal for API intermediates and cost reduction in pharmaceutical manufacturing.
Discover CN101983186B technology for asymmetric hydrogenation. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.
Analysis of patent CN105130842B reveals a novel heterogeneous catalyst for chiral amino alcohol synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101591250A details a streamlined one-step Mannich synthesis and tartaric acid resolution for high-purity chiral amino alcohol ligands, offering significant cost and supply chain advantages.
Patent CN117069602B reveals a cleaner rare earth catalytic route for gamma-amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Ni-catalyzed asymmetric method for chiral quaternary carbon alpha-amino acid esters. High yield, excellent ee, scalable process for API intermediates.
Patent CN116375653A details a high enantioselective iridium-catalyzed method for chiral tetrahydroquinazoline derivatives, offering cost-effective API intermediate manufacturing solutions.
Novel anti-Markovnikov hydroamination method using rare earth catalysts offers high purity pharmaceutical intermediates with reduced environmental impact and simplified supply chains.
Rare earth-catalyzed hydroamination method achieves high-yield gamma-amino alcohol synthesis with simplified process and reduced environmental impact for pharmaceutical manufacturing.
Solve high-cost chiral separation for Abacavir synthesis. 30% yield boost, 40% cost reduction. Scale to 100MT/yr with >99% purity.